CN102670970A - Traditional Chinese medicine composition for treating coronary heart disease - Google Patents
Traditional Chinese medicine composition for treating coronary heart disease Download PDFInfo
- Publication number
- CN102670970A CN102670970A CN2012102157022A CN201210215702A CN102670970A CN 102670970 A CN102670970 A CN 102670970A CN 2012102157022 A CN2012102157022 A CN 2012102157022A CN 201210215702 A CN201210215702 A CN 201210215702A CN 102670970 A CN102670970 A CN 102670970A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating coronary heart disease, which is prepared by the following crude drugs in parts by weight: 20-30 parts of peach juvenile branchlets, 10-20 parts of platycodon grandiflorum, 15-25 parts of pangolin scale, 5-10 parts of herba plantaginis, 10-30 parts of Szechwan Chinaberry fruit, 10-15 parts of codonopsis pilosula, 20-30 parts of allium macrostemon, 5-10 parts of red flowers, 10-15 parts of rhizome chuanxiong, 20-30 parts of caulis spatholobi, 15-25 parts of herba leonuri, 10-25 parts of pericarplum citri reticulatae, 8-12 parts of ccassia twig, 8-12 parts of rhizome atractylodis, 6-12 parts of fructus aurantil, and 4-8 parts of radix ophiopogonis. The traditional Chinese medicine composition for treating coronary heart disease comprises the steps of drying the raw material compositions with the parts, grinding the raw material compositions into ultrafine powder, screening the ultrafine powder with a 300 mesh sieve, and manufacturing the screened ultrafine powder into the oral preparation by adopting a conventional method. The oral preparation comprises capsules, tablets or oral liquid and the like. For the traditional Chinese medicine composition, the raw materials are reasonable in compatibility and supplement each other; the traditional Chinese medicine composition has fast effect on the coronary heart disease, and is accurate in curative effect and has few complications. The traditional Chinese medicine composition for treating coronary heart disease is wide in sources of raw materials, has excellent quality and low price, and is low in cost, thus having popularization and practical values.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, specifically a kind of Chinese medicine composition of treating coronary heart disease.
Background technology
Coronary heart disease is called for short coronary heart disease, is a kind of modal heart disease, common clinically frequently-occurring disease, commonly encountered diseases.Refer to that because lipid metabolism is undesired lipid calmness in the blood is piled up at the lipid material of some similar medicated porridge appearance of endarterium and to be formed white speckle, is called atherosclerotic lesion on the endarterium of otherwise smooth.These specklees increase gradually and cause lumen of artery narrow, and blood flow is obstructed, and cause heart ischemia, produce angina pectoris.
Modern medicine thinks that its pathogenesis is; Because lipid metabolism is undesired, the lipid calmness in the blood is piled up at the lipid material of some similar medicated porridge appearance of endarterium and to be formed white speckle on the endarterium of otherwise smooth; These specklees increase gradually and cause lumen of artery narrow; Blood flow is obstructed, causes heart ischemia, produce angina pectoris.If the speckle on the arterial wall forms ulcer or breaks, will form thrombosis, whole vascular flow is interrupted fully, acute myocardial infarction takes place, even sudden death.The rare pathogenesis of coronary heart disease is coronary vasospasm (blood vessel can not have atherosis), produces ariant angina, if spasm surpasses 30 minutes, also can cause acute myocardial infarction
At present, the method such as the main treatment means one of doctor trained in Western medicine of treatment coronary heart disease are coronary artery dilators, the 2nd, and the formation of anti-tampon and the gathering of thrombosis; Cause the narrow of tube chamber, the minimizing of blood flow, but most of curative effect is unstable; The course of disease is long, outbreak repeatedly, and effect is undesirable.
Summary of the invention
The objective of the invention is provides a kind of Chinese medicine composition of treating coronary heart disease for overcoming the deficiency of above-mentioned prior art, and this Chinese medicine composition is to the coronary heart disease special effect, and curative effect is fast, short treating period, and stable curative effect is difficult for recurrence.
For realizing above-mentioned purpose, the present invention adopts following technical proposals:
A kind of Chinese medicine composition of treating coronary heart disease, it is to be processed by following bulk drugs: Ramulus Persicae 20-30 part, Radix Platycodonis 10-20 part, big gun first 15-25 part, Herba Plantaginis 5-10 part, Fructus Toosendan 10-30, Radix Codonopsis 10-15 part, Bulbus Allii Macrostemonis 20-30 part, Flos Carthami 5-10 part, Rhizoma Chuanxiong 10-15 part, Caulis Spatholobi 20-30 part, Herba Leonuri 15-25 part, Pericarpium Citri Reticulatae 10-15 part, Ramulus Cinnamomi 8-12 part, Rhizoma Atractylodis 8-12 part, Fructus Aurantii 6-12 part, Radix Ophiopogonis 4-8 part.
Wherein the weight portion of each raw material is preferably: 25 parts of Ramulus Persicae, 15 parts of Radix Platycodoniss, 20 parts of big gun first, 8 parts of Herba Plantaginiss, Fructus Toosendan 20,12 parts of Radix Codonopsis, 25 parts of Bulbus Allii Macrostemonis, 8 parts on Flos Carthami, 12 parts of Rhizoma Chuanxiongs, 25 parts of Caulis Spatholobis, 20 parts of Herba Leonuris, 12 parts of Pericarpium Citri Reticulataes, 10 parts of Ramulus Cinnamomi, 10 parts of Rhizoma Atractylodis, 8 parts of Fructus Aurantiis, 6 parts of Radix Ophiopogonis.
The present invention also can add on the pharmaceutics acceptable carrier and/or adjuvant is processed various dosage forms.
The method for preparing of the Chinese medicine composition of said treatment coronary heart disease is: get the umber oven dry of each component raw material, grind impalpable powder, cross 300 mesh sieves, process oral formulations by conventional method and get final product.Said oral formulations comprises capsule, tablet or oral liquid etc.
Raw material of Chinese medicine reasonable compatibility of the present invention complements each other, to the coronary heart disease instant effect, and determined curative effect, complication is few.Raw material sources of the present invention are extensive, super quality and competitive price, and cost is low, has to promote and practical value.
The specific embodiment
Below in conjunction with embodiment the present invention is further specified.
Embodiment 1
A kind of Chinese medicine composition of treating coronary heart disease, it is to be processed by following bulk drugs: Ramulus Persicae 25g, Radix Platycodonis 15g, big gun first 20g, Herba Plantaginis 8g, Fructus Toosendan 20, Radix Codonopsis 12g, Bulbus Allii Macrostemonis 25g, Flos Carthami 8g, Rhizoma Chuanxiong 12g, Caulis Spatholobi 25g, Herba Leonuri 20g, Pericarpium Citri Reticulatae 12g, Ramulus Cinnamomi 10g, Rhizoma Atractylodis 10g, Fructus Aurantii 8g, Radix Ophiopogonis 6g.Impalpable powder is ground in oven dry, crosses 300 mesh sieves, incapsulates, and promptly processes the Chinese medicinal capsule agent of treatment coronary heart disease.
Embodiment 2
A kind of Chinese medicine composition of treating coronary heart disease, it is to be processed by following bulk drugs: Ramulus Persicae 30g, Radix Platycodonis 10g, big gun first 25g, Herba Plantaginis 5g, Fructus Toosendan 10, Radix Codonopsis 15g, Bulbus Allii Macrostemonis 20g, Flos Carthami 5g, Rhizoma Chuanxiong 15g, Caulis Spatholobi 20g, Herba Leonuri 25g, Pericarpium Citri Reticulatae 10g, Ramulus Cinnamomi 10g, Rhizoma Atractylodis 12g, Fructus Aurantii 6g, Radix Ophiopogonis 5g.
Embodiment 3
A kind of Chinese medicine composition of treating coronary heart disease, it is to be processed by following bulk drugs: Ramulus Persicae 30g, Radix Platycodonis 20g, big gun first 20g, Herba Plantaginis 5g, Fructus Toosendan 30, Radix Codonopsis 10g, Bulbus Allii Macrostemonis 30g, Flos Carthami 10g, Rhizoma Chuanxiong 10g, Caulis Spatholobi 20g, Herba Leonuri 20g, Pericarpium Citri Reticulatae 15g, Ramulus Cinnamomi 8g, Rhizoma Atractylodis 10g, Fructus Aurantii 12g, Radix Ophiopogonis 8g.
Embodiment 4
A kind of Chinese medicine composition of treating coronary heart disease, it is to be processed by following bulk drugs: Ramulus Persicae 20g, Radix Platycodonis 15g, big gun first 15g, Herba Plantaginis 10g, Fructus Toosendan 20, Radix Codonopsis 10g, Bulbus Allii Macrostemonis 25g, Flos Carthami 8g, Rhizoma Chuanxiong 13g, Caulis Spatholobi 30g, Herba Leonuri 15g, Pericarpium Citri Reticulatae 10g, Ramulus Cinnamomi 12g, Rhizoma Atractylodis 8g, Fructus Aurantii 10g, Radix Ophiopogonis 4g.
Experimental example 1 man, 70 years old.
From calendar year 2001 uncomfortable in chest, chest pain occurs, breathe hard, the symptom of cardiopalmus, the electrograph inspection is diagnosed as angina pectoris coronary heart disease for coronary insufficiency companion ocular fundus arteriosclerosis, so far year surplus the coronary disease medical history existing 10; In year, the many places treatment is not healed surplus in the of 10, and outbreak repeatedly is from almost outbreak every day over 2007; Send out 2,3 times at most day, cause very big misery to patient, take the capsule 30 days of the embodiment of the invention 1 preparation, disease greatly takes a turn for the better; Continue to take a course of treatment, the state of an illness is able to control, and the number of times that symptom occurs significantly reduces, after continuing to take medicine 3 months; Transference cure, inspection recover normal, after recurrence.
Example 2 patients, woman, 56 years old.
Patient's history 4 years, occur during morbidity cardiopalmus, out of breath, irritated, uncomfortable in chest, breathe hard, the whole body is sleepy, difficulty in walking, edema over the face and pale, body puffiness due to deficiency, indigestion and loss of appetite lack of appetite, abundant expectoration, color are white, purplish tongue is seen in inspection, and petechia is arranged, tongue is greasy in vain, stringy and thready pulse and puckery.The capsule of taking embodiment 1 preparation is after 40 days, and transference cure continues and takes a course of treatment and have an electro-cardiogram, and it is normal that ST-T recovers, and the state of an illness is able to control, after continuing to take medicine 2 months, transference cure, it is normal that inspection recovers, after recurrence.。
Example 3 woman, 49 years old.
Suffered from coronary heart disease 3 years, and nervous cardiopalmus occurred at the beginning of 2009, sensation of oppression over the chest with shortness of breath is examined at certain examination in hospital and to be coronary heart disease.From finding the state of an illness to 2010 end of the year in certain hospital's long-term treatment, effect is little.Began to take this capsule (embodiment 1 preparation) back 20 days from January, 2012, state of an illness basic controlling is taken a course of treatment again, and it is normal that ST-T recovers, and follows the doctor's advice and continued to take medicine one month, follows up a case by regular visits to not recurrence again after January.
Claims (2)
1. Chinese medicine composition of treating coronary heart disease, it is to be processed by following bulk drugs: Ramulus Persicae 20-30, Radix Platycodonis 10-20, big gun first 15-25 part, Herba Plantaginis 5-10 part, Fructus Toosendan 10-30, Radix Codonopsis 10-15 part, Bulbus Allii Macrostemonis 20-30 part, Flos Carthami 5-10 part, Rhizoma Chuanxiong 10-15 part, Caulis Spatholobi 20-30 part, Herba Leonuri 15-25 part, Pericarpium Citri Reticulatae 10-15 part, Ramulus Cinnamomi 8-12 part, Rhizoma Atractylodis 8-12 part, Fructus Aurantii 6-12 part, Radix Ophiopogonis 4-8 part.
2. the Chinese medicine composition of treatment coronary heart disease as claimed in claim 1; It is characterized in that it is to be processed by following bulk drugs: Ramulus Persicae 25, Radix Platycodonis 15,20 parts of big gun first, 8 parts of Herba Plantaginiss, Fructus Toosendan 20,12 parts of Radix Codonopsis, 25 parts of Bulbus Allii Macrostemonis, 8 parts on Flos Carthami, 12 parts of Rhizoma Chuanxiongs, 25 parts of Caulis Spatholobis, 20 parts of Herba Leonuris, 12 parts of Pericarpium Citri Reticulataes, 10 parts of Ramulus Cinnamomi, 10 parts of Rhizoma Atractylodis, 8 parts of Fructus Aurantiis, 6 parts of Radix Ophiopogonis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102157022A CN102670970A (en) | 2012-06-28 | 2012-06-28 | Traditional Chinese medicine composition for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102157022A CN102670970A (en) | 2012-06-28 | 2012-06-28 | Traditional Chinese medicine composition for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102670970A true CN102670970A (en) | 2012-09-19 |
Family
ID=46803955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102157022A Pending CN102670970A (en) | 2012-06-28 | 2012-06-28 | Traditional Chinese medicine composition for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102670970A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1546067A (en) * | 2003-09-15 | 2004-11-17 | 史 忠 | Chinese traditional medicine for treating coronary disease and angina |
| CN101104072A (en) * | 2006-07-12 | 2008-01-16 | 闫文丛 | Medicine for curing angiocardiopathy and cerebrovascular disease and its preparing method |
| CN102078510A (en) * | 2011-01-24 | 2011-06-01 | 孙华清 | Chinese medicinal composition for treating coronary heart disease |
-
2012
- 2012-06-28 CN CN2012102157022A patent/CN102670970A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1546067A (en) * | 2003-09-15 | 2004-11-17 | 史 忠 | Chinese traditional medicine for treating coronary disease and angina |
| CN101104072A (en) * | 2006-07-12 | 2008-01-16 | 闫文丛 | Medicine for curing angiocardiopathy and cerebrovascular disease and its preparing method |
| CN102078510A (en) * | 2011-01-24 | 2011-06-01 | 孙华清 | Chinese medicinal composition for treating coronary heart disease |
Non-Patent Citations (2)
| Title |
|---|
| 周志焕: "天王补心丹临证运用集萃", 《北京中医药》 * |
| 金镖等: "升陷汤治疗老年人冠心病心绞痛37例", 《陕西中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100457176C (en) | Chinese medicinal preparation for curriculum of physical and fatigue reducing | |
| CN101584797B (en) | Application of traditional Chinese medicine composition in preparing medicament for treating climacteric syndrome | |
| CN101584796B (en) | Application of traditional Chinese medicine composition in preparing medicament for treating melancholia | |
| CN100488539C (en) | Pharmaceutical composition for promoting blood circulation and preparation method thereof | |
| CN101829315B (en) | Traditional Chinese medicine composition for treating headache during menstruation and preparation method thereof | |
| CN101099775B (en) | Cardiac and cerebral vascular disease treating medicine | |
| CN103055201B (en) | Chinese medicinal herb composition for treating coronary heart disease and preparation method thereof | |
| CN102008688B (en) | Medicament for treating periodic psychosis | |
| CN102727627B (en) | Traditional Chinese medicine composition for treating heart failure and preparation method and application thereof | |
| CN102204956B (en) | Chinese medicinal composition used at stroke recovery period and preparation method thereof | |
| CN102670970A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104758732A (en) | Chinese herba preparation for treating metabolic syndrome | |
| CN102579804B (en) | Chinese medicine for treating stenocardia | |
| CN107913315A (en) | A kind of Chinese medicine composition for treating refractory hypertension and preparation method thereof | |
| CN101524514B (en) | Medicament for curing central serous chorioretinopathy (CSCR) and preparation method thereof | |
| CN101716271B (en) | Chinese traditional medicine effective fraction composite used for curing coronary heart disease and preparation method thereof | |
| CN106620253A (en) | Traditional Chinese medicine composition for treating bradyarrhythmia | |
| CN110215454B (en) | Composition with effects of reducing blood sugar and blood fat and application thereof | |
| CN104208571A (en) | Traditional Chinese medicinal composition for treating cardiovascular stenosis | |
| CN100396297C (en) | Compsn. of Chinese traditional medicine in use for treating cardiovascular diseases | |
| CN104398867B (en) | A kind of pharmaceutical composition for treating arrhythmia cordis coronary heart disease | |
| CN106309939A (en) | Medicine for treating headache | |
| CN104435927B (en) | It is a kind of to treat cardiovascular narrow Chinese medicine composition and preparation method thereof | |
| CN102836348A (en) | Novel traditional Chinese medicine formula for treatment of hepatopathy | |
| CN102232997A (en) | Medicament for treating myocardial ischemia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120919 |